|
OMIM |
Link |
Information gain |
01 |
|
TG
|
[NCBI]
|
0.00340562
|
|
|
enteropathy, protein-losing
|
[NCBI]
|
0.00254657
|
|
|
CHNG3
|
[NCBI]
|
0.00202368
|
|
|
thyroid hormonogenesis, genetic defect in, 4
|
[NCBI]
|
0.00160371
|
|
|
MNG1
|
[NCBI]
|
0.0015281
|
|
|
SLC6A3
|
[NCBI]
|
0.000545807
|
|
|
EGF
|
[NCBI]
|
0.000471406
|
|
|
PD
|
[NCBI]
|
0.000451534
|
|
|
thyrotropin deficiency, isolated
|
[NCBI]
|
0.000383754
|
|
|
PDS
|
[NCBI]
|
0.000366335
|
|
|
CMH
|
[NCBI]
|
0.000310989
|
|
|
VIP
|
[NCBI]
|
0.000296415
|
|
|
CEACAM5
|
[NCBI]
|
0.000264655
|
|
|
melanoma, uveal
|
[NCBI]
|
0.000216344
|
|
|
apnea, obstructive sleep
|
[NCBI]
|
0.000213028
|
|
|
SLC6A4
|
[NCBI]
|
0.00017351
|
|
|
TPO
|
[NCBI]
|
0.000151517
|
|
|
CHNG2
|
[NCBI]
|
0.00014601
|
|
|
amenorrhea-galactorrhea syndrome
|
[NCBI]
|
0.000141283
|
|
|
thrombocytopenia, cyclic
|
[NCBI]
|
0.000141283
|
|
|
papillary thyroid microcarcinoma
|
[NCBI]
|
0.000141283
|
|
|
thyroid hormonogenesis, genetic defect in, 2a
|
[NCBI]
|
0.000133113
|
|
|
VEGF
|
[NCBI]
|
0.000131255
|
|
|
CCK
|
[NCBI]
|
0.000110393
|
|
|
hypercholesterolemia, autosomal dominant, type b
|
[NCBI]
|
0.000109738
|
|
|
WARBM
|
[NCBI]
|
0.000109738
|
|
|
MJD
|
[NCBI]
|
0.000103012
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
9.55209e-05
|
|
|
carboxypeptidase n deficiency
|
[NCBI]
|
9.01631e-05
|
|
|
thyroid hormonogenesis, genetic defect in, 1
|
[NCBI]
|
8.44513e-05
|
|
|
RA
|
[NCBI]
|
8.41755e-05
|
|
|
TTR
|
[NCBI]
|
8.29262e-05
|
|
|
ragweed sensitivity
|
[NCBI]
|
7.9909e-05
|
|
|
lipomatosis, familial benign cervical
|
[NCBI]
|
7.9909e-05
|
|
|
TF
|
[NCBI]
|
7.89206e-05
|
|
|
thyroxine-binding globulin of serum
|
[NCBI]
|
7.61393e-05
|
|
|
thrombasthenia of glanzmann and naegeli
|
[NCBI]
|
7.3723e-05
|
|
|
FTC
|
[NCBI]
|
7.29188e-05
|
|
|
myasthenic syndrome, congenital, fast-channel
|
[NCBI]
|
7.29188e-05
|
|
|
thyrotoxic periodic paralysis
|
[NCBI]
|
7.29188e-05
|
|
|
NMB
|
[NCBI]
|
7.20353e-05
|
|
|
NPPA
|
[NCBI]
|
7.16734e-05
|
|
|
GRTH
|
[NCBI]
|
7.01089e-05
|
|
|
PGL4
|
[NCBI]
|
7.01089e-05
|
|
|
PCNA
|
[NCBI]
|
6.64607e-05
|
|
|
ARH
|
[NCBI]
|
6.33529e-05
|
|
|
pineal hyperplasia, insulin-resistant diabetes mellitus, and somatic abnormalities
|
[NCBI]
|
6.14978e-05
|
|
|
ACHE
|
[NCBI]
|
5.96859e-05
|
|
|
NBIA1
|
[NCBI]
|
5.82063e-05
|
|
|
KLK3
|
[NCBI]
|
5.73676e-05
|
|
|
hyperlipoproteinemia, type ii
|
[NCBI]
|
5.53531e-05
|
|
|
CHNG1
|
[NCBI]
|
5.28374e-05
|
|
|
dopamine beta-hydroxylase deficiency, congenital
|
[NCBI]
|
5.28374e-05
|
|
|
LPG
|
[NCBI]
|
5.28374e-05
|
|
|
GFAP
|
[NCBI]
|
5.18704e-05
|
|
|
mucopolysaccharidosis type iiib
|
[NCBI]
|
4.95504e-05
|
|
|
TH
|
[NCBI]
|
4.95211e-05
|
|
|
NPY
|
[NCBI]
|
4.77619e-05
|
|
|
hyperimmunoglobulin e recurrent infection syndrome, autosomal dominant
|
[NCBI]
|
4.76154e-05
|
|
|
lecithin:cholesterol acyltransferase deficiency
|
[NCBI]
|
4.67118e-05
|
|
|
PYY
|
[NCBI]
|
4.53475e-05
|
|
|
PGL1
|
[NCBI]
|
4.50156e-05
|
|
|
MG
|
[NCBI]
|
4.48262e-05
|
|
|
graves disease
|
[NCBI]
|
4.19962e-05
|
|
|
GAL
|
[NCBI]
|
4.15427e-05
|
|
|
thyroid carcinoma, papillary
|
[NCBI]
|
4.13072e-05
|
|
|
LRP1
|
[NCBI]
|
4.00811e-05
|
|
|
GTS
|
[NCBI]
|
3.96703e-05
|
|
|
IDE
|
[NCBI]
|
3.95876e-05
|
|
|
ADCYAP1
|
[NCBI]
|
3.92647e-05
|
|
|
AR
|
[NCBI]
|
3.91935e-05
|
|
|
CALCRL
|
[NCBI]
|
3.77278e-05
|
|
|
TNF
|
[NCBI]
|
3.70157e-05
|
|
|
LQT1
|
[NCBI]
|
3.59951e-05
|
|
|
LPO
|
[NCBI]
|
3.30642e-05
|
|
|
TBG
|
[NCBI]
|
3.24042e-05
|
|
|
IGFALS
|
[NCBI]
|
3.16383e-05
|
|
|
NGFB
|
[NCBI]
|
3.1007e-05
|
|
|
CAT
|
[NCBI]
|
2.66321e-05
|
|
|
MEN2A
|
[NCBI]
|
2.64978e-05
|
|
|
MPO
|
[NCBI]
|
2.60385e-05
|
|
|
SLC18A3
|
[NCBI]
|
2.5244e-05
|
|
|
LDLRAP1
|
[NCBI]
|
2.40961e-05
|
|
|
GRP
|
[NCBI]
|
2.24938e-05
|
|
|
CF
|
[NCBI]
|
2.20286e-05
|
|
|
CFTR
|
[NCBI]
|
2.07237e-05
|
|
|
ADM
|
[NCBI]
|
2.01387e-05
|
|
|
CCR2
|
[NCBI]
|
1.97093e-05
|
|
|
LRP2
|
[NCBI]
|
1.92196e-05
|
|
|
APCS
|
[NCBI]
|
1.90789e-05
|
|
|
MAS
|
[NCBI]
|
1.89858e-05
|
|
|
CUBN
|
[NCBI]
|
1.87543e-05
|
|
|
ADA
|
[NCBI]
|
1.82529e-05
|
|
|
hypercholesterolemia, autosomal dominant
|
[NCBI]
|
1.78744e-05
|
|
|
giant platelet syndrome
|
[NCBI]
|
1.73492e-05
|
|
|
MMSDH
|
[NCBI]
|
1.70609e-05
|
|
|
RLN3R1
|
[NCBI]
|
1.70609e-05
|
|
|
F3
|
[NCBI]
|
1.64736e-05
|
|
|
GAPDH
|
[NCBI]
|
1.55628e-05
|
|
|
KSS
|
[NCBI]
|
1.54264e-05
|
|
|
TSHR
|
[NCBI]
|
1.53853e-05
|
|
|
ITLN1
|
[NCBI]
|
1.52746e-05
|
|
|
alkaline phosphatase, intestinal, fetal form
|
[NCBI]
|
1.52746e-05
|
|
|
POMC
|
[NCBI]
|
1.47139e-05
|
|
|
PXE
|
[NCBI]
|
1.44202e-05
|
|
|
CRC
|
[NCBI]
|
1.30176e-05
|
|
|
CLU
|
[NCBI]
|
1.3005e-05
|
|
|
MBP
|
[NCBI]
|
1.28027e-05
|
|
|
FXYD1
|
[NCBI]
|
1.22732e-05
|
|
|
AVP
|
[NCBI]
|
1.21928e-05
|
|
|
KCNE3
|
[NCBI]
|
1.20466e-05
|
|
|
IL13RA1
|
[NCBI]
|
1.20466e-05
|
|
|
CPN1
|
[NCBI]
|
1.20466e-05
|
|
|
GALR2
|
[NCBI]
|
1.20466e-05
|
|
|
ribonucleic acid, ribosomal, 5s
|
[NCBI]
|
1.20466e-05
|
|
|
PPARA
|
[NCBI]
|
1.11664e-05
|
|
|
factor x deficiency
|
[NCBI]
|
1.10737e-05
|
|
|
PZP
|
[NCBI]
|
1.08906e-05
|
|
|
CHAT
|
[NCBI]
|
1.08544e-05
|
|
|
APOB
|
[NCBI]
|
1.08025e-05
|
|
|
ANGPTL3
|
[NCBI]
|
1.06744e-05
|
|
|
HSD17B6
|
[NCBI]
|
1.06744e-05
|
|
|
ERBB3
|
[NCBI]
|
1.06744e-05
|
|
|
EPOR
|
[NCBI]
|
1.01942e-05
|
|
|
AHR
|
[NCBI]
|
9.73806e-06
|
|
|
SEMA3B
|
[NCBI]
|
9.60841e-06
|
|
|
MTNR1A
|
[NCBI]
|
9.60841e-06
|
|
|
CRH
|
[NCBI]
|
9.34005e-06
|
|
|
DIO2
|
[NCBI]
|
8.74076e-06
|
|
|
C5R1
|
[NCBI]
|
8.74076e-06
|
|
|
PSPN
|
[NCBI]
|
8.74076e-06
|
|
|
RAMP1
|
[NCBI]
|
8.36173e-06
|
|
|
TYMS
|
[NCBI]
|
8.304e-06
|
|
|
SLC27A1
|
[NCBI]
|
8.0122e-06
|
|
|
IAPP
|
[NCBI]
|
7.99357e-06
|
|
|
SSTR5
|
[NCBI]
|
7.68824e-06
|
|
|
PRLH
|
[NCBI]
|
7.60276e-06
|
|
|
HGF
|
[NCBI]
|
7.49606e-06
|
|
|
CYP1A1
|
[NCBI]
|
7.48357e-06
|
|
|
TNC
|
[NCBI]
|
7.44448e-06
|
|
|
LDLR
|
[NCBI]
|
7.44057e-06
|
|
|
GALR1
|
[NCBI]
|
7.38664e-06
|
|
|
AS
|
[NCBI]
|
7.3528e-06
|
|
|
CD36
|
[NCBI]
|
7.27127e-06
|
|
|
CTGF
|
[NCBI]
|
6.903e-06
|
|
|
CCL18
|
[NCBI]
|
6.84041e-06
|
|
|
TRHR
|
[NCBI]
|
6.84041e-06
|
|
|
GNRH1
|
[NCBI]
|
6.62652e-06
|
|
|
PMCH
|
[NCBI]
|
6.47023e-06
|
|
|
P4HB
|
[NCBI]
|
6.35718e-06
|
|
|
SLC5A5
|
[NCBI]
|
5.9252e-06
|
|
|
SSTR2
|
[NCBI]
|
5.9252e-06
|
|
|
MC2R
|
[NCBI]
|
5.9252e-06
|
|
|
CHRNA1
|
[NCBI]
|
5.9252e-06
|
|
|
GHRHR
|
[NCBI]
|
5.9252e-06
|
|
|
NRTN
|
[NCBI]
|
5.53571e-06
|
|
|
FGF1
|
[NCBI]
|
5.20521e-06
|
|
|
SDC2
|
[NCBI]
|
4.90943e-06
|
|
|
MAG
|
[NCBI]
|
4.88483e-06
|
|
|
CHRNE
|
[NCBI]
|
4.85898e-06
|
|
|
PGR
|
[NCBI]
|
4.72927e-06
|
|
|
PPIB
|
[NCBI]
|
4.70759e-06
|
|
|
SPINK1
|
[NCBI]
|
4.5786e-06
|
|
|
FPRL1
|
[NCBI]
|
4.56236e-06
|
|
|
HD
|
[NCBI]
|
4.53097e-06
|
|
|
MC1R
|
[NCBI]
|
4.50748e-06
|
|
|
HPX
|
[NCBI]
|
4.15983e-06
|
|
|
TFPI
|
[NCBI]
|
4.01762e-06
|
|
|
SLC26A4
|
[NCBI]
|
3.80042e-06
|
|
|
GRPR
|
[NCBI]
|
3.68898e-06
|
|
|
PAI1
|
[NCBI]
|
3.68898e-06
|
|
|
LPL
|
[NCBI]
|
3.53137e-06
|
|
|
SST
|
[NCBI]
|
3.33254e-06
|
|
|
FY
|
[NCBI]
|
3.27942e-06
|
|
|
PCI
|
[NCBI]
|
3.12823e-06
|
|
|
LIF
|
[NCBI]
|
3.09397e-06
|
|
|
ACP5
|
[NCBI]
|
3.06297e-06
|
|
|
MST1
|
[NCBI]
|
3.00556e-06
|
|
|
PSCA
|
[NCBI]
|
2.75609e-06
|
|
|
PLG
|
[NCBI]
|
2.62426e-06
|
|
|
SPP1
|
[NCBI]
|
2.53898e-06
|
|
|
PRL
|
[NCBI]
|
2.13327e-06
|
|
|
CJD
|
[NCBI]
|
2.1304e-06
|
|
|
LHCGR
|
[NCBI]
|
2.12665e-06
|
|
|
TFRC
|
[NCBI]
|
2.066e-06
|
|
|
PNMT
|
[NCBI]
|
2.06007e-06
|
|
|
GNRHR
|
[NCBI]
|
1.94952e-06
|
|
|
GHR
|
[NCBI]
|
1.89199e-06
|
|
|
MDD
|
[NCBI]
|
1.81443e-06
|
|
|
DBI
|
[NCBI]
|
1.71965e-06
|
|
|
CNTF
|
[NCBI]
|
1.60647e-06
|
|
|
BTC
|
[NCBI]
|
1.58703e-06
|
|
|
FGF7
|
[NCBI]
|
1.44073e-06
|
|
|
GHRH
|
[NCBI]
|
1.42809e-06
|
|
|
CCR5
|
[NCBI]
|
1.36534e-06
|
|
|
NMU
|
[NCBI]
|
1.32427e-06
|
|
|
THRB
|
[NCBI]
|
1.1699e-06
|
|
|
EPO
|
[NCBI]
|
1.07505e-06
|
|
|
B2M
|
[NCBI]
|
1.06384e-06
|
|
|
SLE
|
[NCBI]
|
1.03651e-06
|
|
|
BDNF
|
[NCBI]
|
9.60634e-07
|
|
|
GDNF
|
[NCBI]
|
9.43447e-07
|
|
|
PWS
|
[NCBI]
|
8.98968e-07
|
|
|
LCAT
|
[NCBI]
|
8.5054e-07
|
|
|
SHBG
|
[NCBI]
|
8.0397e-07
|
|
|
APOE
|
[NCBI]
|
7.9955e-07
|
|
|
AD
|
[NCBI]
|
7.75834e-07
|
|
|
UGB
|
[NCBI]
|
7.62439e-07
|
|
|
HLA-A
|
[NCBI]
|
7.10707e-07
|
|
|
TP53
|
[NCBI]
|
7.00877e-07
|
|
|
OXT
|
[NCBI]
|
5.91437e-07
|
|
|
IL2
|
[NCBI]
|
5.72829e-07
|
|
|
CCL22
|
[NCBI]
|
5.4911e-07
|
|
|
ABP1
|
[NCBI]
|
4.67288e-07
|
|
|
CPE
|
[NCBI]
|
3.97423e-07
|
|
|
SRC
|
[NCBI]
|
3.80686e-07
|
|
|
PTGS2
|
[NCBI]
|
3.80686e-07
|
|
|
PEDF
|
[NCBI]
|
3.64388e-07
|
|
|
JAK2
|
[NCBI]
|
3.2608e-07
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
3.17931e-07
|
|
|
PF4
|
[NCBI]
|
2.95099e-07
|
|
|
OSM
|
[NCBI]
|
2.75978e-07
|
|
|
PIGR
|
[NCBI]
|
2.37481e-07
|
|
|
CP
|
[NCBI]
|
1.75139e-07
|
|
|
ACPP
|
[NCBI]
|
1.69737e-07
|
|
|
antithrombin iii deficiency
|
[NCBI]
|
1.33217e-07
|
|
|
NF1
|
[NCBI]
|
1.28224e-07
|
|
|
TLR9
|
[NCBI]
|
1.24694e-07
|
|
|
GIP
|
[NCBI]
|
1.23843e-07
|
|
|
HFE
|
[NCBI]
|
7.68077e-08
|
|
|
PLAUR
|
[NCBI]
|
6.2008e-08
|
|
|
INSR
|
[NCBI]
|
5.65176e-08
|
|
|
UCN
|
[NCBI]
|
4.17062e-08
|
|
|
panencephalitis, subacute sclerosing
|
[NCBI]
|
3.28683e-08
|
|
|
SERPINA6
|
[NCBI]
|
2.7454e-08
|
|
|
RB1
|
[NCBI]
|
2.56873e-08
|
|
|
EGFR
|
[NCBI]
|
1.7027e-08
|
|
|
PTH
|
[NCBI]
|
1.47522e-08
|
|
|
AFP
|
[NCBI]
|
1.29479e-08
|
|
|
ACE
|
[NCBI]
|
1.13209e-08
|
|
|
PTHLH
|
[NCBI]
|
6.20028e-09
|
|
|
FGFR2
|
[NCBI]
|
3.37313e-09
|
|
|
PLK1
|
[NCBI]
|
7.87146e-10
|
|
|
LEP
|
[NCBI]
|
6.14175e-11
|
|
|
ALB
|
[NCBI]
|
3.04397e-11
|
|